Intermediate uveitis and alopecia areata: Is there a relationship? Report of 3 pediatric cases

Pediatrics

Volumn 128, Issue 4, 2011, Pages

  Ayuso, Viera Kalinina ^a   Pott, Jan Willem ^b   De Boer, Joke Helena ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Dermatology; Immunology; Uveitis

Indexed keywords

ACETAZOLAMIDE; ANTINUCLEAR ANTIBODY; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE; DOUBLE STRANDED DNA ANTIBODY; LYSOZYME; NEUTROPHIL CYTOPLASMIC ANTIBODY; RHEUMATOID FACTOR;

ADOLESCENT; ALOPECIA AREATA; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CHILD; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG INTERMITTENT THERAPY; FEMALE; HAIR LOSS; HUMAN; INTERMEDIATE UVEITIS; MALE; MEDICAL ASSESSMENT; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; REMISSION; RETINA MACULA CYSTOID EDEMA; SCHOOL CHILD; TREATMENT OUTCOME; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION; VITRECTOMY;

ADOLESCENT; ALOPECIA AREATA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; UVEITIS, INTERMEDIATE;

EID: 80053546538     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-0142     Document Type: Article

References (32)

1. Nagpal A, Leigh JF, Acharya NR. Epidemiology of uveitis in children. Int Ophthalmol Clin. 2008;48(3):1-7
2. Jain R, Ferrante P, Reddy GT, Lightman S. Clinical features and visual outcome of intermediate uveitis in children. Clin Experiment Ophthalmol. 2005;33(1):22-25 (Pubitemid 40330971)
3. De Boer J, Berendschot TT, van der DP, Rothova A. Long-term follow-up of intermediate uveitis in children. Am J Ophthalmol. 2006;141(4):616-621
4. Kalinina Ayuso V, ten Cate HA, van den Does P, Rothova A, De Boer JH. Young age as a risk factor for complicated course and visual outcome in intermediate uveitis in children. Br J Ophthalmol. 2011;95(5):646-651
5. Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ 3rd. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc. 1995;70(7):628-633
6. Kos L, Conlon J. An update on alopecia areata. Curr Opin Pediatr. 2009;21(4):475-480
7. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509-516 (Pubitemid 41224845)
8. Barahmani N, Schabath MB, Duvic M. History of atopy or autoimmunity increases risk of alopecia areata. J Am Acad Dermatol. 2009;61(4):581-591
9. Pearlman RB, Golchet PR, Feldmann MG, et al. Increased prevalence of autoimmunity in patients with white spot syndromes and their family members. Arch Ophthalmol. 2009;127(7):869-874
10. Prahalad S, Shear ES, Thompson SD, Giannini EH, Glass DN. Increased prevalence of familial autoimmunity in simplex and multiplex families with juvenile rheumatoid arthritis. Arthritis Rheum. 2002;46(7):1851-1856 (Pubitemid 34774517)
11. García LA, Carroll MO, Garza León MA. Vogt-Koyanagi-Harada syndrome in childhood. Int Ophthalmol Clin. 2008;48(3):107-117
12. Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131(5):647-652 (Pubitemid 32422124)
13. Brown AC, Pollard ZF, Jarrett WH. Ocular and testicular abnormalities in alopecia areata. Arch Dermatol. 1982;118(8):546-554 (Pubitemid 12099932)
14. Pandhi D, Singal A, Gupta R, Das G. Ocular alterations in patients of alopecia areata. J Dermatol. 2009;36(5):262-268
15. Recupero SM, Abdolrahimzadeh S, De Dominicis M, et al. Ocular alterations in alopecia areata. Eye (Lond). 1999;13(pt 5):643-646 (Pubitemid 29511837)
16. Tosti A, Colombati S, Caponeri GM, et al. Ocular abnormalities occurring with alopecia areata. Dermatologica. 1985;170(2):69-73 (Pubitemid 15164826)
17. Hoepf M, Laby DM. Optic neuropathy in a child with alopecia. Optom Vis Sci. 2010;87(10):E787-E789
18. Gregoriou S, Papafragkaki D, Kontochristopoulos G, Rallis E, Kalogeromitros D, Rigopoulos D. Cytokines and other mediators in alopecia areata. Mediators Inflamm. 2010; 2010:928030
19. Muhaya M, Calder VL, Towler HM, Jolly G, McLauchlan M, Lightman S. Characterization of phenotype and cytokine profiles of T cell lines derived from vitreous humour in ocular inflammation in man. Clin Exp Immunol. 1999;116(3):410-414 (Pubitemid 29258088)
20. Murphy CC, Duncan L, Forrester JV, Dick AD. Systemic CD4(+) T cell phenotype and activation status in intermediate uveitis. Br J Ophthalmol. 2004;88(3):412-416 (Pubitemid 38333724)
21. Pedroza-Seres M, Linares M, Voorduin S, et al. Pars planitis is associated with an increased frequency of effector-memory CD57+ T cells. Br J Ophthalmol. 2007;91(10):1393-1398 (Pubitemid 47492882)
22. Gilhar A, Paus R, Kalish RS. Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest. 2007;117(8):2019-2027 (Pubitemid 47219540)
23. Wasserman D, Guzman-Sanchez DA, Scott K, McMichael A. Alopecia areata. Int J Dermatol. 2007;46(2):121-131 (Pubitemid 46679412)
24. Perez VL, Papaliodis GN, Chu D, Anzaar F, Christen W, Foster CS. Elevated levels of interleukin 6 in the vitreous fluid of patients with pars planitis and posterior uveitis: the Massachusetts eye & ear experience and review of previous studies. Ocul Immunol Inflamm. 2004;12(3):193-201 (Pubitemid 39424882)
25. Dudda-Subramanya R, Alexis AF, Siu K, Sinha AA. Alopecia areata: genetic complexity underlies clinical heterogeneity. Eur J Dermatol. 2007;17(5):367-374 (Pubitemid 47425901)
26. Alaez C, Arellanes L, Vazquez A, et al. Classic pars planitis: strong correlation of class II genes with gender and some clinical features in Mexican Mestizos. Hum Immunol. 2003;64(10):965-972 (Pubitemid 37210848)
27. Raja SC, Jabs DA, Dunn JP, et al. Pars planitis: clinical features and class II HLA associations. Ophthalmology. 1999;106(3):594-599 (Pubitemid 30191598)
28. Tang WM, Pulido JS, Eckels DD, Han DP, Mieler WF, Pierce K. The association of HLA-DR15 and intermediate uveitis. Am J Ophthalmol. 1997;123(1):70-75 29
29. de Smet, Chan CC. Regulation of ocular inflammation: what experimental and human studies have taught us. Prog Retin Eye Res. 2001;20(6):761-797
30. Alexis AF, Dudda-Subramanya R, Sinha AA. Alopecia areata: autoimmune basis of hair loss. Eur J Dermatol. 2004;14(6):364-370 (Pubitemid 39551596)
31. Caspi RR. Ocular autoimmunity: the price of privilege? Immunol Rev. 2006;213:23-35 (Pubitemid 44401491)
32. Streilein JW, Ohta K, Mo JS, Taylor AW. Ocular immune privilege and the impact of intraocular inflammation. DNA Cell Biol. 2002;21(5-6):453-459 (Pubitemid 35034588)